ChromoGenics AB announced order intake for the third quarter of 2023 amounts to SEK 8.3 million, a considerably higher level than the previous quarter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.88 SEK | +0.20% | 0.00% | +41.14% |
05-30 | Swedish Energy Agency Converts ChromoGenics' SEK48 Million Loan to Grant | MT |
05-23 | ChromoGenics AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.14% | 6.25M | |
+17.29% | 15.45B | |
+39.47% | 8.44B | |
+6.79% | 2.43B | |
+14.45% | 1.09B | |
+12.82% | 735M | |
+4.43% | 425M | |
-1.36% | 341M | |
+6.28% | 223M | |
+17.92% | 199M |
- Stock Market
- Equities
- CHRO Stock
- News ChromoGenics AB
- ChromoGenics AB Discloses Order Intake for the Third Quarter 2023